A dual-targeting PDGFRβ/VEGF-A molecule assembled from stable antibody fragments demonstrates anti-angiogenic activity in vitro and in vivo

Authors:
  • DGDebra G. Gilbertson
    Debra G. Gilbertson
  • AFAmanda Frank
    Amanda Frank
  • TVTuyen Vu
    Tuyen Vu
  • DADan Ardourel
    Dan Ardourel
  • COCraig Ostrander
    Craig Ostrander
  • BSBrenda L. Stevens
    Brenda L. Stevens
  • SJSusan H. Julien
    Susan H. Julien
  • SFSecil Franke
    Secil Franke
  • BMBrent Meengs
    Brent Meengs
  • JBJennifer Brody
    Jennifer Brody
  • SPScott Presnell
    Scott Presnell

Abstract
Targeting angiogenesis is a promising approach to the treatment of solid tumors and age-related macular degeneration (AMD). Inhibition of vascularization has been validated by the successful market...

This publication has 45 references indexed in Scilit: